How long an antipsychotic stays in your system depends heavily on which drug you take, what form it comes in, and several personal factors. At one extreme, oral quetiapine clears your blood in a day or two. At the other, a long-acting injectable like paliperidone palmitate given every three months can still be measurable months after the last shot. The general pharmacological rule is that a drug is essentially gone after about five half-lives, but “gone from your blood” and “gone from your brain” turn out to be different timelines, and that gap matters more than most people realize.
What Half-Life Actually Tells You
A drug’s half-life is the time it takes for the amount in your blood to drop by half. After one half-life, half remains. After two, a quarter. After five half-lives, less than about 3% of the original dose is left, which is typically considered negligible.1PubMed. The Practical Importance of Half-Life in Psychopharmacology For oral antipsychotics, this “five half-lives to clear” rule gives you a reasonable estimate of when the drug is out of your bloodstream. If a drug has a six-hour half-life, you are looking at roughly 30 hours. If it has a 75-hour half-life, clearing takes over two weeks.
But the rule comes with caveats. If you have been taking a drug for weeks or months, it has reached steady state in your body, meaning tissue stores have built up. Stopping means your blood level may decline a bit more slowly than the simple half-life math predicts, because drug stored in fat and other tissues seeps back into the blood as levels fall. Lipophilic antipsychotics accumulate extensively in tissues, which inflates their volume of distribution and can extend the tail end of elimination.2PubMed. Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions
Oral Antipsychotics and Their Wide Range
Among oral antipsychotics, the spread in half-life is enormous. Quetiapine has one of the shortest, with a half-life around six to seven hours. Its immediate-release form often needs to be taken twice a day, and even the extended-release version is dosed once daily because the formulation slows absorption, not because the drug itself lasts long.3PubMed Central. Role of extended release quetiapine in the management of bipolar disorders Within about 30 to 40 hours of your last dose, quetiapine is essentially undetectable in blood.
Olanzapine sits in a middle range, with a half-life typically around 21 to 54 hours depending on the person. Haloperidol, one of the older first-generation drugs, ranges from about 12 to 36 hours. Clozapine’s published half-life is about 12 hours, though real-world elimination can behave differently, as discussed later in the overdose section.
At the long end, oral aripiprazole has a half-life of roughly 75 hours, and its active metabolite (dehydro-aripiprazole) lasts even longer at around 94 hours. That means aripiprazole can take two to three weeks to fully clear from your body after you stop it. Paliperidone extended-release also falls in the longer-lasting category. Both drugs’ long half-lives mean their blood levels stay remarkably stable between doses, with very little of the peak-and-trough fluctuation you see with shorter-acting drugs.4PubMed Central. Predicting pharmacokinetic stability by multiple oral administration of atypical antipsychotics
Long-Acting Injectables Are a Different Category Entirely
Long-acting injectable antipsychotics (LAIs) change the timeline dramatically. These formulations are injected into muscle or under the skin, and the drug is absorbed very slowly from the injection site into the bloodstream over weeks or months. This creates what pharmacologists call “flip-flop” kinetics: instead of the drug being absorbed quickly and then eliminated, the absorption itself is the bottleneck, and it controls how long the drug stays in your system.5PubMed Central. Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview Once the drug finally reaches the bloodstream, it is eliminated at the same rate as the oral version. But because the injection site keeps releasing drug for so long, the “apparent half-life” of an LAI is far longer than its oral counterpart.
The numbers make this concrete. After a single injection of aripiprazole once-monthly at the 400-mg dose, the elimination half-life was about 547 hours, or roughly 23 days. After multiple monthly injections reached steady state, the half-life stretched to about 1,139 hours, nearly 47 days.6PubMed Central. Single- and multiple-dose pharmacokinetics, safety, and tolerability of Aripiprazole once-monthly, long-acting intramuscular injection for Chinese adults with schizophrenia At five half-lives, that means detectable drug could persist for the better part of a year after your last injection.
Paliperidone palmitate follows a similar pattern. The once-monthly injection (PP1M) has an apparent half-life measured in weeks, and the three-monthly injection (PP3M) stretches even further. A discontinuation comparison found that the median time to relapse after stopping oral paliperidone was 58 days, versus 172 days for the once-monthly injectable and 395 days for the three-monthly injectable.7PubMed. Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone The longer residual drug coverage from the injection depot accounts for much of this protection.
Your Brain Holds On Longer Than Your Blood
Here is where the question “how long does it stay in your system” gets more complicated than a blood test can answer. Antipsychotics work by binding to receptors in the brain, primarily dopamine D2 receptors. And the drug can remain attached to those receptors well after blood levels have dropped. For risperidone, the half-life of its plasma concentration was about 18 hours, but the half-life of its dopamine D2 receptor occupancy in the brain was about 80 hours, more than four times longer.8PubMed. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics Quetiapine showed a similar mismatch: its receptor occupancy half-life was roughly 10 hours, about twice the plasma half-life.9PubMed. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia
This matters practically. Even after the drug is undetectable in blood, receptor blockade can linger. Side effects like sedation or movement-related symptoms can persist beyond what a blood test would predict, and so can therapeutic effects. The flip side is that receptor occupancy does eventually fade, and when it drops below a certain threshold, the risk of symptom return climbs.
Active metabolites add another layer. Risperidone is converted in the liver to 9-hydroxy-risperidone (paliperidone), which is pharmacologically active and often present at higher concentrations than the parent drug itself.10Progress in Neuro-Psychopharmacology and Biological Psychiatry. Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone When clinicians talk about risperidone’s “active moiety,” they mean the combined concentration of the parent drug plus this metabolite, which has a longer half-life than risperidone alone. If you only looked at risperidone’s own half-life, you would underestimate how long the drug’s effects last.
Factors That Speed Up or Slow Down Elimination
Antipsychotics are processed primarily by liver enzymes belonging to the cytochrome P450 family. Different drugs rely on different enzymes: clozapine and olanzapine are metabolized mainly by CYP1A2, risperidone primarily by CYP2D6, and quetiapine by CYP3A4.11PubMed Central. Interactions between the cytochrome P450 system and the second-generation antipsychotics Anything that revs up or slows down these enzymes changes how fast you clear the drug.
Smoking
Cigarette smoke contains compounds that strongly induce CYP1A2. For olanzapine and clozapine, which depend on that enzyme, smoking noticeably speeds up elimination and lowers blood levels.12BMJ Open. Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine In one study, the dose-adjusted concentration of olanzapine was roughly 40% lower in smokers than in non-smokers.13PubMed Central. Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia If you smoke and then quit, the drug suddenly clears more slowly, which can push blood levels up and intensify side effects. Doctors may need to adjust the dose after a change in smoking status.
Age and Kidney Function
Aging and impaired kidney function slow elimination, particularly for drugs with renally excreted metabolites. For risperidone’s active moiety, clearance drops by about 30% in older adults and by about 50% in people with kidney disease, and the half-life stretches from about 19 hours to about 25 hours.14PubMed. Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man Liver cirrhosis, interestingly, did not significantly change risperidone’s pharmacokinetics in that same study, though it can matter for drugs more heavily dependent on hepatic processing.
Drug Interactions
Adding or removing another medication that affects the same CYP enzymes can change how long an antipsychotic sticks around. Most drug interactions with second-generation antipsychotics occur at the metabolism stage, when another drug either inhibits or induces the relevant enzyme.15PubMed Central. A review of pharmacokinetic and pharmacodynamic interactions with antipsychotics A common example: the antidepressant fluvoxamine strongly inhibits CYP1A2, which can cause clozapine and olanzapine levels to rise substantially. Conversely, the anti-seizure drug carbamazepine induces CYP3A4, which speeds up clearance of quetiapine. Any time a new medication is started or stopped, the antipsychotic’s effective half-life can shift without anyone changing the antipsychotic dose itself.
How Long Antipsychotics Show Up on Drug Tests
Standard drug screens used for employment or legal purposes do not typically test for antipsychotics. These are prescription medications, not controlled substances in the usual sense. But specialized urine assays can detect them, and they are sometimes used in clinical settings to check whether a patient is actually taking their medication.
In a pilot study that tested urine samples from patients known to be taking antipsychotics, all samples came back positive for the drug the patient was prescribed. Urine concentrations varied widely: haloperidol ranged up to 417 ng/mL, quetiapine up to about 4,000 ng/mL, risperidone up to about 1,000 ng/mL, and olanzapine from 57 to 700 ng/mL.16PubMed. Urine testing for antipsychotics: a pilot trial for a method to determine detection levels Because urine concentrations lag behind blood levels, a drug that has already cleared your bloodstream may still be detectable in urine for an additional day or two. For long-acting injectables with their extended release profiles, urine positivity would persist correspondingly longer.
What Happens When You Stop
A drug being gone from your blood does not mean your brain has instantly adjusted. The rate at which an antipsychotic leaves your system has real consequences for relapse risk. When antipsychotic treatment is stopped abruptly, relapses tend to cluster in the weeks and months immediately following cessation rather than spreading out evenly over time. This clustering suggests that at least some of the early relapses are withdrawal-related, triggered by the sudden drop in receptor blockade rather than a natural return of the underlying illness.17PubMed Central. A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Gradual tapering appears to reduce this withdrawal effect. When patients in one study were tapered off over as long as 18 months, relapses were distributed much more evenly over time, without the sharp spike seen after abrupt stopping. This distinction between true relapse and withdrawal-associated relapse has important implications for anyone considering discontinuation. A faster taper removes drug from the brain more abruptly, and even after accounting for how long the drug physically remains in the body, abrupt oral cessation carries a substantially higher relapse risk than discontinuing a long-acting injectable, which by nature provides a slow, built-in taper as the depot gradually empties.18Schizophrenia Bulletin. Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse
When Overdose Changes the Rules
In overdose situations, the usual half-life estimates can go out the window. A documented case of clozapine overdose showed symptoms and elevated blood levels persisting far beyond what the drug’s published 12-hour half-life would predict. Serum clozapine concentrations plateaued for about four days before finally beginning to decline, and clinical recovery tracked the eventual drop rather than the expected timeline. The takeaway from that case report was blunt: in overdose, clozapine may not behave as its published pharmacokinetics predict.19The Journal of Emergency Medicine. Delayed recovery associated with persistent serum concentrations after clozapine overdose
This likely happens because at very high doses, the liver enzymes responsible for metabolizing the drug become saturated. Instead of the usual first-order kinetics, where the rate of elimination is proportional to the amount of drug present, the system shifts to zero-order kinetics: the liver can only process a fixed amount per hour regardless of how much is circulating. The result is a much slower decline than expected, with clinical toxicity dragging on for days.
Pregnancy and Placental Transfer
For people taking antipsychotics during pregnancy, the question shifts from “how long does it stay in my system” to “how much reaches the baby.” Antipsychotics do cross the placenta, but the degree varies by drug. A study of late-pregnancy exposure found that olanzapine had the highest placental passage ratio at about 72%, followed by haloperidol at about 66%, risperidone at about 49%, and quetiapine at the lowest at about 24%.20PubMed. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes
After birth, the newborn can no longer rely on the mother’s liver and kidneys to clear the drug. Neonatal liver enzymes are immature, so elimination in the baby is considerably slower. This means that even a drug with a relatively short half-life in adults can linger in a newborn for a disproportionately long time. Quetiapine’s low placental passage makes it a drug that exposes the fetus to comparatively less medication, though the decision about which antipsychotic to use in pregnancy involves weighing many factors beyond just pharmacokinetics.
Bariatric Surgery and Absorption Changes
Gastric bypass procedures like the Roux-en-Y alter the anatomy of the digestive tract in ways that can change how oral medications are absorbed. A significant portion of the stomach and small intestine is bypassed, reducing the surface area available for drug absorption and potentially changing the acidity and transit time that many drugs depend on for proper dissolution.21PubMed. Roux-en-Y Gastric Bypass and Antipsychotic Therapeutic Drug Monitoring: Two Cases
For someone taking an oral antipsychotic after bariatric surgery, this can mean lower absorption and therefore lower blood levels than expected from the same dose. The drug might effectively leave the system faster, not because elimination is faster, but because less entered in the first place. Extended-release formulations, which rely on controlled dissolution along the length of the gut, may be particularly affected. Therapeutic drug monitoring becomes especially valuable in these patients, because standard dosing guidelines were developed for people with intact gastrointestinal anatomy, and the assumptions behind those guidelines no longer hold.